Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D3 vs 25(OH)D3 in Vitamin D Deficiency
NCT02091219Phase 1Completed
- Sponsor
- University of California, Los Angeles
- Start
- Jun 2014
- Primary completion
- Dec 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised trial of calcifediol in Vitamin D deficiency (VDD) (2 arms), sponsored by University of California, Los Angeles. Primary endpoint: Change in total serum 25-hydroxyvitamin D at 16 weeks. Started Jun 2014; status: completed.
02
Drugs
calcifediol
03
Conditions
Vitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT02091219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02091219.